SCHEMBL14788859

SCHEMBL14788859

NC(CC(C[18F])CCCC(=O)O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 3/20 0.48
SLC1A1 P43005 3/20 0.48
SLC1A3 P43003 2/20 0.48
GRM8 O00222 2/20 0.48
GRM6 O15303 2/20 0.48
GRIK1 P39086 2/20 0.48
GRIK2 Q13002 2/20 0.48
GRM7 Q14831 2/20 0.48
GRM4 Q14833 2/20 0.48
GRIN2D O15399 1/20 0.48
GRIN3B O60391 1/20 0.48
GSR P00390 1/20 0.48
CYP1A2 P05177 1/20 0.48
GRM5 P41594 1/20 0.48
GRIA1 P42261 1/20 0.48
GRIA2 P42262 1/20 0.48
GRIA3 P42263 1/20 0.48
GRIA4 P48058 1/20 0.48
GRIN1 Q05586 1/20 0.48
GRIN2A Q12879 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6924307 0.82 GSR (0.48) SLC1A2SLC1A1SLC1A3GRM8GRM6
SCHEMBL5284965 0.80 SLC7A5 (0.52) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL18762428 0.80 SLC7A5 (0.52) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
Hydrochloric Acid SCHEMBL18762515 0.78 SLC7A5 (0.50) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
Hydrochloric Acid SCHEMBL18762516 0.78 SLC7A5 (0.50) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL14788852 0.78 SLC1A2 (0.52) SLC1A2SLC1A1SLC1A3GRM8GRM6
SCHEMBL28267787 0.77 GRM8 (0.67) SLC1A2SLC1A1SLC1A3GRM8GRM6
(S)-2-Aminoadipic Acid SCHEMBL2022365 0.76 GSR (0.73) SLC1A2SLC1A1SLC1A3GRM8GRM6
(S)-2-Aminoadipic Acid SCHEMBL41328 0.76 GSR (0.73) SLC1A2SLC1A1SLC1A3GRM8GRM6
(S)-2-Aminoadipic Acid SCHEMBL97323 0.76 GSR (0.73) SLC1A2SLC1A1SLC1A3GRM8GRM6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130071332-A1 LABELED MOLECULAR IMAGING AGENTS AND METHODS OF USE GENERAL ELECTRIC COMPANY (US) 2013-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130071332-A1 LABELED MOLECULAR IMAGING AGENTS AND METHODS OF USE SLC7A11, GLS, SLC3A2 SLC1A2 5/4885SLC1A1 4/4885SLC1A3 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.